Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 1 results out of 1
Data Insights
AB-207 by Angiocrine Bioscience for Anal Fissure: Likelihood of Approval
AB-207 is under clinical development by Angiocrine Bioscience and currently in Phase I for Anal Fissure. According to GlobalData, Phase...